Cancers arise as a result of a series of genetic mutations. A better understanding of the consequences of these mutations on the underlying biology of the neoplastic cells will help to focus the development of more effective therapies. Cancer stem cells have now been recognized in a wide variety of human tumors. The existence of cancer stem cells poses challenges and alluring potential for our ability to successfully combat cancer. This symposium aims to bring together scientists who are interested in better understanding the mechanisms by which cancer stem cells contribute to tumor heterogeneity, self-renewal and drug resistance. We believe that this is an area of rapid progress in understanding cancer stem cell with immense potential to benefit human health.
This flagship event will host Dr. Michael Clarke, as a plenary speaker. Dr. Clarke’s laboratory was the first to identify breast cancer stem cells, a minority population of cancer cells that are responsible for the growth and spread of breast cancer, a process called metastasis.
Friday, February 1st, 2019 at 8:00 AM to 5:45 PM
It is a great pleasure and an honor to extend a warm invitation to all the participants from all over the world to attend the One day Symposium on “Stem Cells and Cancer – India 2018”, on February 5th , 2018 at Somaiya Vidyavihar, Mumbai, India
The Symposium is jointly organized by Sathgen Biotech (A division of Godavari Biorefineries Ltd.) and National Centre for Cell Sciences (NCCS) and supported by Somaiya Vidyavihar.
The theme for this year is woven around Cancer stem cells, its significance in Drug Discovery research and its future for Targeted Therapy. The symposium will host Dr. Michael Clarke, a Karel and Avice Beekhuis Professor in Cancer Biology and Associate Director of the Stanford Institute for Stem Cell and Regenerative Medicine as a plenary speaker for the symposium along with other dignitaries known in the field of Cancer stem cells & EMT pathway.
The Symposium will provide a wonderful forum to explore the innovations in cancer stem cells, circulating tumor cells and the EMT pathway. The symposium will strive to offer plenty of networking opportunities, to meet and interact with the leading scientists and researchers, as well as sponsors and exhibitors.
We look forward to your participation for a symphony of outstanding science & research.